Key result
A fast transition from surgical to endovascular operations for aneurysmal subarachnoid hemorrhage yielded similar 1-year case fatality rate decreases in transitioned non-MCA and non-transitioned MCA aneurysms.
Why the study?
Prior studies attributed decreasing aSAH case fatality rates to increasing endovascular treatment without accounting for improvements in other factors, leaving the independent effect of treatment modality on fatality uncertain.
Does a fast transition from surgical to endovascular operations reduce 1-year case fatality rates in patients with aneurysmal subarachnoid hemorrhage?
Cohort (n=557)
No
Does a fast transition from surgical to endovascular operations reduce 1-year case fatality rates in patients with aneurysmal subarachnoid hemorrhage?
A fast transition from surgical to endovascular treatment for aneurysmal subarachnoid hemorrhage did not independently improve case fatality rates beyond the general temporal improvements seen across all treatment modalities.
Answers are grounded in this paper and cite their sources.
Endovascular transition showed no independent survival benefit in aSAH; leaves open whether modality effects exceed secular trends.
BACKGROUND: Several studies have attributed decreasing case fatality rates (CFRs) of aneurysmal subarachnoid hemorrhage (aSAH) to the gradually increasing use of endovascular treatment without considering improvements in other outcome-affecting factors. To assess the independent effect of a treatment modality on CFRs, we investigated CFR changes in a high-volume center rapidly transitioning from surgical to endovascular operations as the first-line treatment for all aSAH patients except those with middle cerebral artery (MCA) aneurysms. METHODS: We identified all surgically/endovascularly treated aSAH patients in Helsinki University Hospital (HUH) during 2012-2017. As the treatment shift occurred in 2015, we defined two treatment eras: surgical (2012-2014) and endovascular (2015-2017). We compared time-dependent changes in 1-year CFRs between non-MCA and MCA patients using a Poisson regression model. To analyze consistency in operation rates, we also identified sudden-death and conservatively treated aSAHs in the HUH catchment area via two externally validated registers. RESULTS: Of all 665 hospitalized aSAH cases in the HUH catchment area, 557 (84%) received operative treatment; 367 (66%) underwent surgical and 190 (34%) endovascular operations. Between the treatment eras, endovascular treatment for non-MCA cases increased from 21 to 79%, whereas 99% of the MCA cases were treated surgically during the whole study-period. Among the operatively treated patients, the 1-year CFRs decreased similarly in patients with non-MCA (42%; from 14 to 8%; adjusted risk ratio (aRR) = 0.66 (95% CI 0.37-1.19)) and MCA aneurysms (42%; from 15 to 9%; aRR = 0.66 (0.16-1.60)). The proportion of operatively treated patients, their clinical condition on admission, and amount of bleeding on the first CT-scan remained unchanged over time. CONCLUSIONS: We found similar CFR decreases in aSAH groups with and without undergoing a fast transition from surgery to endovascular operations, providing real-world evidence on the small independent effect of endovascular treatment on the decreasing CFRs in high-volume centers.
No takes yet. Share an insight, caveat, or question.
Asikainen et al. (2025) conducted a cohort in Aneurysmal subarachnoid hemorrhage (aSAH) (n=557). Fast treatment transition to endovascular operations (Endovascular era 2015-2017) vs. Surgical treatment era (2012-2014) was evaluated on 1-year case fatality rate in non-MCA aneurysms (aRR 0.66, 95% CI 0.37-1.19, p=0.168). A fast transition from surgical to endovascular operations for aneurysmal subarachnoid hemorrhage yielded similar 1-year case fatality rate decreases in transitioned non-MCA and non-transitioned MCA aneurysms.
Synapse has enriched 10 related papers. Consider them for comparative context: